Stay updated on SL-401 Combo in AML/MDS/BPDCN Clinical Trial

Sign up to get notified when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as detailed information on various hematologic diseases and treatments, including a new clinical trial reference. Some previously listed terms and conditions have been removed.
    Difference
    8%
    Check dated 2025-08-31T12:23:36.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.9%
    Check dated 2025-08-24T08:10:19.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.7%
    Check dated 2025-08-17T04:43:06.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.6%
    Check dated 2025-08-10T00:36:20.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    2%
    Check dated 2025-08-02T19:31:13.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    1%
    Check dated 2025-07-26T15:22:15.000Z thumbnail image

Stay in the know with updates to SL-401 Combo in AML/MDS/BPDCN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.